A company discovering new drugs for a range of diseases based on the genomes of hibernating animals is raising $9 million in seed funds. . . . → Read More: Animal Genome Biotech Raises $9M in Seed Funds
|
|||||
       
  |
The technology intelligence company CB Insights reported on new investments in digital therapeutics and found a record-setting funding pace this year. . . . → Read More: Infographic – Digital Therapeutics Funding on the Rise 
A company developing neuroscience data collection and analytics tools for clinicians and researchers raised $22.8 million in its first venture round. . . . → Read More: Neuroscience Software Company Raises $23M in Early Funds 
A company developing more precise immunotherapies for cancer and other diseases is raising $108 million in its second venture funding round. . . . → Read More: Immunotherapy Biotech Gains $108M in New Funds  One comment - (Comments are closed)  Finance, New products  biomedical, biotechnology, cancer, entrepreneurs, equity, investment, life sciences, pharmaceuticals, university, venture capital 
A one year-old biotechnology company developing treatments for diseases of microglia cells in the brain, is raising $90 million in new venture funds. . . . → Read More: Biotech Start-Up Gains $90M for Neurodegenerative Diseases Comments are closed Finance, New products biomedical, biotechnology, entrepreneurs, equity, genomics, investment, licensing, life sciences, pharmaceuticals, preclinical, university, venture capital 
A developer of drugs from psychedelic compounds for mental health conditions is raising $80 million in its second venture funding round. . . . → Read More: Psychedelic Therapy Company Raises $80M in New Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, clinical trials, entrepreneurs, equity, investment, life sciences, pharmaceuticals, psychiatric, U.K., venture capital 
Two statistical indicators provide more evidence that innovations in health and medicine are continuing their sharp upward climb. . . . → Read More: Infographic – Biomedical Innovation Gains Continue Comments are closed Business conditions, New products biomedical, clinical trials, FDA, life sciences, medical device, pharmaceuticals, statistics, venture capital 
A start-up company creating synthetic blood vessels for transplants, based on research in materials science and cell biology, is raising $2.2 million in seed funds. . . . → Read More: Synthetic Blood Vessel Maker Gains $2.2M in Seed Funds Comments are closed Finance, New products biomedical, biotechnology, chemistry, engineering, entrepreneurs, equity, Europe, investment, life sciences, materials science, medical device, physical sciences, university, venture capital 
A developer of treatments for people with amyotrophic lateral sclerosis, or ALS, is raising $135 million in its third venture financing round. . . . → Read More: ALS Drug Maker Gains $135M in New Funds Comments are closed Finance, New products biomedical, biotechnology, clinical trials, entrepreneurs, equity, investment, life sciences, pharmaceuticals, venture capital 
Venture funding for Black-owned start-ups in the U.S. rose to record levels in the first half of 2021, but the percentage of total funding remains low. . . . → Read More: Infographic – 2021 Black Start-Up Funding Rises |
|
|||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
